Trial Profile

Virginia Opioid Overdose Treatment InitiatVE

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 17 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Buprenorphine (Primary) ; Buprenorphine/naloxone (Primary)
Indications Opioid-related disorders
Focus Therapeutic Use
Acronyms VOTIVE

Most Recent Events

09 Apr 2021 Status changed from suspended to discontinued.
05 Mar 2021 Status changed from recruiting to suspended, due to a financial business decision by the company supporting the research study (Indivior).The decision was not due to adverse events, safety reasons, or scientific reasons, but was abusiness decision.
11 Dec 2020 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com